Susan G. Komen® Welcomes Removal of Black Box Warning from Some Hormone Therapies for Menopause
U.S. Food and Drug Administration Guidance Confirms Vaginal Estrogen Therapy Doesn’t Increase Breast Cancer Risk WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, today expressed its support for the removal of a black box warning label on vaginal estrogen therapies that help alleviate dryness and irritation caused by menopause. The label […]
